# CVS Health (CVS) — Analyst Forecast

CVS · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/cvs/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 27 | 3 | 0 | 30 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $108.00 | $115.83 | $125.00 | 6 |

Last price $92.58 (as of Oct 15, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 12, 2026 | Leerink Partners | Maintained | Outperform | $112.00 |
| Sep 3, 2026 | UBS | Maintained | Buy | $118.00 |
| Aug 19, 2026 | Argus Research | Maintained | Buy | $114.00 |
| Aug 12, 2026 | JP Morgan | Maintained | Overweight | $118.00 |
| Aug 6, 2026 | Barclays | Maintained | Overweight | $108.00 |
| Aug 6, 2026 | Evercore ISI Group | Maintained | Outperform | $125.00 |
| Aug 6, 2026 | UBS | Maintained | Buy | $126.00 |
| Jul 24, 2026 | UBS | Maintained | Buy | $122.00 |
| Jul 14, 2026 | Truist Securities | Maintained | Buy | $118.00 |
| Jul 13, 2026 | Wells Fargo | Maintained | Overweight | $123.00 |
| Jul 9, 2026 | RBC Capital | Maintained | Outperform | $113.00 |
| Jul 7, 2026 | Cantor Fitzgerald | Maintained | Overweight | $110.00 |
| Jun 23, 2026 | B of A Securities | Maintained | Buy | $110.00 |
| Jun 8, 2026 | Mizuho | Maintained | Outperform | $115.00 |
| Jun 4, 2026 | Morgan Stanley | Maintained | Overweight | $111.00 |
| Jun 1, 2026 | Truist Securities | Maintained | Buy | $108.00 |
| May 26, 2026 | Barclays | Maintained | Overweight | $106.00 |
| May 20, 2026 | Mizuho | Maintained | Outperform | $110.00 |
| May 14, 2026 | Morgan Stanley | Maintained | Overweight | $106.00 |
| May 13, 2026 | Bernstein | Maintained | Outperform | $106.00 |

## Frequently Asked Questions

### What is the price target for CVS stock?

The average 12-month analyst price target for CVS Health (CVS) is $115.83, with a high estimate of $125.00 and a low of $108.00, across 6 analysts.

### Is CVS a buy, sell, or hold?

Analysts covering CVS Health currently average a Buy rating: 27 buy, 3 hold and 0 sell, from 30 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for CVS?

The average price target of $115.83 implies 25.12% upside from the last price of $92.58.

### What is the latest analyst rating on CVS?

On Oct 12, 2026, Leerink Partners maintained CVS Health at Outperform with a price target of $112.00.

## Similar Stocks

- [UNH](https://www.lighthorse.io/tickers/unh) — UnitedHealth Group Incorporated Common Stock (DE)
- [WMT](https://www.lighthorse.io/tickers/wmt) — Walmart Inc. - Common Stock
- [AMZN](https://www.lighthorse.io/tickers/amzn) — Amazon.com, Inc. - Common Stock
- [HUM](https://www.lighthorse.io/tickers/hum) — Humana Inc. Common Stock
- [CI](https://www.lighthorse.io/tickers/ci) — The Cigna Group Common Stock
- [ELV](https://www.lighthorse.io/tickers/elv) — Elevance Health, Inc. Common Stock
- [PFE](https://www.lighthorse.io/tickers/pfe) — Pfizer, Inc. Common Stock

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).